Biostatistics Shared Resource (BSR) The BSR provides comprehensive biostatistics support of cancer research for MCC investigators. The resource was established in 1995 and Dr. Messer (CP), a nationally recognized biostatistician, has been the BSR Director since the prior renewal in 2006. Additional leadership of the BSR is provided by Dr. Natarajan (CP), a very experienced mathematician and biostatistician, and Dr. Baru, a world-renowned leader in informatics infrastructure at the SD Supercomputer Center (SDSC). The BSR also provides database and informatics services for cancer studies, collaborating with SDSC and Clinical and Translational Research Institute (CTRI). The BSR comprises 10.9 FTE of cancer-funded effort, including 5 faculty in the Division of Biostatistics in Family and Preventive Medicine, a senior leader at the SD Supercomputer Center, a faculty member with appointments in both the Department of Computer Science and at SDSU's Graduate School of Public Health, and 9 biostatistics, bioinformatics and informatics staff at the PhD or Master's level. Three faculty and all staff have offices on the third floor of the MCC building, creating a Biostatistics suite with well-defined signage. Key biostatistics objectives of the BSR include support of new grant applications, and support for design, monitoring, analysis, interpretation of results and manuscript preparation for cancer-related studies. Key informatics objectives include database design, development and support; integration of diverse software and web applications; and electronic data capture for clinical trials and patient registries, including pullback from EPIC medical record. BSR services are divided between short-term consulting, supported by the CCSG without charge to MCC investigators, and longer-term collaboration that is funded from collaborative grants. Service requests are accepted in person, by phone, email, or web request, and are tracked using a web-based system. During the period 2007-2012, the BSR supported 130 different MCC investigators resulting in 133 co-authored cancer-related, peer-reviewed papers, and 255 grant submissions. Furthermore, the BSR assisted in developing 80 therapeutic protocols. In 2012, 51 MCC members representing all six programs used BSR services accounting for 99% of shared resource utilization, and the BSR received 18% of its funding from the CCSG. This is a continuing shared resource.

Public Health Relevance

The Biostatistics Shared Resource (BSR) provides MCC investigators with statistical expertise to assist in the design and analysis of cancer-related studies. BSR biostatisticians ensure that clinical trials and other studies have well defined end-points and rigorous analysis plans, and are designed for maximal efficiency To ensure a high scientific standard in data analysis and interpretation of study results.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA023100-32
Application #
9478980
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2018-05-01
Budget End
2019-04-30
Support Year
32
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of California, San Diego
Department
Type
DUNS #
804355790
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Connor, Michael; Karunamuni, Roshan; McDonald, Carrie et al. (2017) Regional susceptibility to dose-dependent white matter damage after brain radiotherapy. Radiother Oncol 123:209-217
Ly, Peter; Teitz, Levi S; Kim, Dong H et al. (2017) Selective Y centromere inactivation triggers chromosome shattering in micronuclei and repair by non-homologous end joining. Nat Cell Biol 19:68-75
Sundaramoorthy, Sriramkumar; Garcia Badaracco, Adrian; Hirsch, Sophia M et al. (2017) Low Efficiency Upconversion Nanoparticles for High-Resolution Coalignment of Near-Infrared and Visible Light Paths on a Light Microscope. ACS Appl Mater Interfaces 9:7929-7940
D'Antonio, Matteo; Woodruff, Grace; Nathanson, Jason L et al. (2017) High-Throughput and Cost-Effective Characterization of Induced Pluripotent Stem Cells. Stem Cell Reports 8:1101-1111
Guo, Shicheng; Diep, Dinh; Plongthongkum, Nongluk et al. (2017) Identification of methylation haplotype blocks aids in deconvolution of heterogeneous tissue samples and tumor tissue-of-origin mapping from plasma DNA. Nat Genet 49:635-642
Jiang, Qingfei; Crews, Leslie A; Holm, Frida et al. (2017) RNA editing-dependent epitranscriptome diversity in cancer stem cells. Nat Rev Cancer 17:381-392
Martínez, María Elena; Gomez, Scarlett L; Tao, Li et al. (2017) Contribution of clinical and socioeconomic factors to differences in breast cancer subtype and mortality between Hispanic and non-Hispanic white women. Breast Cancer Res Treat 166:185-193
Krishnan, A P; Karunamuni, R; Leyden, K M et al. (2017) Restriction Spectrum Imaging Improves Risk Stratification in Patients with Glioblastoma. AJNR Am J Neuroradiol 38:882-889
Connor, Michael J; Marshall, Deborah C; Moiseenko, Vitali et al. (2017) Adverse Events Involving Radiation Oncology Medical Devices: Comprehensive Analysis of US Food and Drug Administration Data, 1991 to 2015. Int J Radiat Oncol Biol Phys 97:18-26
Panopoulos, Athanasia D; D'Antonio, Matteo; Benaglio, Paola et al. (2017) iPSCORE: A Resource of 222 iPSC Lines Enabling Functional Characterization of Genetic Variation across a Variety of Cell Types. Stem Cell Reports 8:1086-1100

Showing the most recent 10 out of 805 publications